Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
G Protein-coupled Receptor
100%
M3 muscarinic Acetylcholine Receptor
100%
Insulin Secretion
100%
Glucose-stimulated Insulin Secretion
66%
Type 2 Diabetes Prevention
50%
M3 muscarinic Receptor
50%
Receptor Signaling
33%
Diabetes
33%
PKD1
33%
Type 2 Diabetes Mellitus (T2DM)
33%
Putative Drug Targets
33%
Gandhi
33%
Receptor-mediated
33%
Novel Pathways
33%
Receptor Phosphorylation
33%
Antidiabetic Drug
16%
Gs-coupled Receptor
16%
β-arrestin
16%
Glucagon-like peptide-1 Receptor Agonists (GLP-1 RAs)
16%
Growth Factors
16%
B Cells
16%
Thiazolidinediones
16%
Drug Class
16%
Meglitinides
16%
Dipeptidyl peptidase-4 (DPP-4)
16%
Pancreatic Islets
16%
Molecular Targets
16%
Prolonged Release
16%
Gliptins
16%
PKC Pathway
16%
Signaling Pathway
16%
Plethora
16%
Digestion
16%
Molecular Pathways
16%
Insulin
16%
Tyrosine Kinase
16%
Potential Identification
16%
Type-specific
16%
Receptor Agonist
16%
Smooth muscle
16%
Glucose Tolerance
16%
β-Cell Survival
16%
Sulfonylurea
16%
Phosphorylation
16%
Exenatide
16%
Selective Activation
16%
Serotonin
16%
Transgenic Mice
16%
Calcium Signaling
16%
FASEB
16%
Differential Susceptibility
16%
Pharmacological Management
16%
Receptor Tyrosine Kinase
16%
Cephalic Phase
16%
Nuclear Receptor
16%
Receptor Recruitment
16%
Cooperative Regulation
16%
Insulin Release
16%
Airway Smooth muscle
16%
P70S6K
16%
GRK2
16%
Bhattacharyya
16%
Liraglutide
16%
Mitogenic Signaling
16%
Lixisenatide
16%
Future Medicine
16%
Muscle Growth
16%
Therapeutic Target
16%
KATP Channel
16%
Biguanides
16%
Coupled Growth
16%
Arrestin
16%
Desensitization
16%
Biochemistry, Genetics and Molecular Biology
Insulin Release
100%
G Protein Coupled Receptor
100%
Muscarinic Acetylcholine Receptor M3
60%
Glucose
50%
Maturity Onset Diabetes of the Young
50%
Muscarinic Acetylcholine Receptor
30%
phosphorylation
30%
Arrestin
20%
Biochemistry
20%
Receptor Agonists
20%
Protein Kinases
20%
P70S6 Kinase
10%
Muscle Growth
10%
Signal Transduction
10%
Cell Survival
10%
Thiazolidinedione
10%
Sulfonylurea
10%
Growth Factor
10%
Nuclear Receptor
10%
Insulin
10%
Adenosine Triphosphate Sensitive Potassium Channel
10%
Liraglutide
10%
Glucagon-Like Peptide 1 Receptor
10%
Serotonin
10%
Transgenic Mouse
10%
Receptor Tyrosine Kinase
10%
Agonist
10%
Pharmacology, Toxicology and Pharmaceutical Science
G Protein Coupled Receptor
100%
Insulin
100%
Muscarinic Receptor
54%
Maturity Onset Diabetes of the Young
45%
Glucose
45%
Receptor
36%
Muscarinic M3 Receptor
27%
Protein Kinases
18%
Retina S Antigen
18%
Meglitinide
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Protein Tyrosine Kinase
9%
Fatty Acid
9%
Dipeptidyl Peptidase IV Inhibitor
9%
Liraglutide
9%
Sulfonylurea
9%
Lixisenatide
9%
Desensitization
9%
Muscle Growth
9%
Biguanide Derivative
9%
Transgenic Mouse
9%
Thiazolidinedione
9%
Receptor Agonist
9%
Cell Nucleus Receptor
9%
Exendin 4
9%
Growth Factor
9%
Adenosine Triphosphate Sensitive Potassium Channel
9%
Molecular Target
9%
Antidiabetic Agent
9%
Serotonin
9%
Phosphotransferase
9%